Yes I think the same also, CR is imminent should happen just now.
Unless there is a pending transaction at Corporate level, they need to raise the capital to avoid the risk of increasing funding cost.
All Generic players are struggling.
- Forums
- ASX - By Stock
- ACR
- Ann: Appendix 4E and FY22 Annual Report
Ann: Appendix 4E and FY22 Annual Report, page-19
Featured News
Add ACR (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.79M |
Open | High | Low | Value | Volume |
4.4¢ | 4.4¢ | 4.4¢ | $820 | 18.64K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 98384 | 4.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.6¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 98384 | 0.044 |
2 | 547000 | 0.043 |
2 | 94414 | 0.041 |
3 | 322500 | 0.040 |
1 | 120000 | 0.039 |
Price($) | Vol. | No. |
---|---|---|
0.046 | 10000 | 1 |
0.047 | 24318 | 1 |
0.048 | 144500 | 4 |
0.049 | 120000 | 1 |
0.052 | 103000 | 2 |
Last trade - 10.00am 18/11/2024 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
SPONSORED BY The Market Online